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ABSTRACT
Objective: This objective of this research was to study in vitro antimalarial activity of chloroform, n-butanol, and ethyl acetate fractions of ethanol 
extracts of Carthamus tinctorius Linn. flowers from Asteraceae family which empirically been used as traditional medication by people in South 
Sulawesi to heal measles.
Methods: Fractionation was conducted using chloroform, n-butanol, and ethyl acetate. Determination of antimalarial activity was performed by 
in vitro test using the 24-well microplate and the candle-jar method. Breeding is done in a petri-dish and done aseptically. Plasmodium falciparum 3D7 
culture obtained from frozen deposits in-thawing and bread from Pharmacy Laboratory of Airlangga University, Surabaya, Indonesia. Blood sample 
with a density of over 2000 was employed. Serial decreasing concentrations of the crude extract of chloroform, butanol, and ethyl acetate fraction 
were tested for antimalarial activity. The following concentrations were used; 100; 10; 1.0; 0.1; and 0.01 (mg/mL). Negative controls used dimethyl 
sulfoxide (DMSO) diluted in the same manner as diluting materials above test, to obtain final DMSO concentration is not more than 0.5%. Mixture and 
suspension test parasites (= test preparation) are then inserted into the candle-jar and incubated in a CO2 incubator at a temperature of 37°C for 48 h. 
After incubation for 48 h made a thin blood smear on glass object. Smear dried at room temperature, fixed with methanol, then, once dry stained with 
Giemsa and counted under a microscope parasitemianya with 1000 times magnification. Calculations performed on 5000’s erythrocytes.
Results: Results showed that chloroform and n-butanol fraction cannot inhibit parasitemia >50%, but ethyl acetate fraction can inhibit parasitemia 
>50% with the highest inhibition at 100 µg/mL of 94.48%.
Conclusion: Ethyl acetate fraction is highly active as antimalarial with an IC50 of 1.25 µg/mL.
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INTRODUCTION
Malaria is an infectious disease caused by protozoa of the genus 
Plasmodium. This disease contributes to the high rate of mortality 
among infants, under-five children, and pregnant women. Annually, 
more than 500 people worldwide are infected by malaria and 1 million 
died due to this disease. The majority of malarial cases occur in Africa, 
as well as in several countries in Asia, South America, Middle East, and 
Europe. To deal with the disease, the 60th meeting of the World Health 
Assembly has come up with a global commitment on the elimination 
of malaria in all countries. Guidance on how to go about doing this has 
been provided by the World Health Organization through its Global 
Malaria Program [1].
Indonesia is one of the countries at the risk of malaria. Most of 
Indonesian regions are malaria-endemic, in particular, the eastern part 
of the country including Papua, Maluku, Nusa Tenggara, Sulawesi, and 
Kalimantan, as well as some areas in Lampung, Bengkulu, and Riau. In 
some areas of Java and Bali, despite low endemism, cases of malaria 
outbreaks still occur frequently. In 2007, 396 out of 495 regencies 
in Indonesia are malaria-endemic, and it was estimated that 45% of 
the population live in areas that are at high risk of malaria infection. 
In addition, malaria morbidity in the country is reported to rise from 
year to year. To overcome malaria disease, various efforts have been 
made both in global and national scale. Malaria is one of the indicators 
of Millennium Development Goals, with an aim at putting a stop to the 
spread of malaria and reducing malaria-related incidents in 2015, to be 
indicated by a decrease in morbidity and mortality caused by malaria [2].
One factor, leading to some problems faced in the eradication of malaria, 
is a decrease in the efficacy of antimalarial drugs that have commonly 
been taken. Plasmodium falciparum has been reported to be resistant 
to antimalarial chloroquine. Reports also indicate that resistance to 
chloroquine, sulfadoxine-pyrimethamine, mefloquine, halofantrine, and 
quinine occur in some areas in Southeast Asia. In certain areas within the 
region, a combination of artemisinin and its derivatives is the only effective 
medication [3]. Other factors leading to the still high rate of morbidity 
and mortality include large-scale human migration, environmental and 
climate change, poor health-care system, and the emergence of strains 
of insecticide-resistant Anopheles mosquitos [4]. However, this has 
drawn the attention of the researcher and active research is going on for 
the exploration of new sources of lead molecules that can be eventually 
developed into potential alternative antimalarial drugs [5].
An alternative way of preventing malaria is by developing a concept of 
immunotherapy medication, that is, an administration of drugs in the 
form of either synthetic or natural compounds (plants) that are capable 
of optimizing the functions of all components in human body immune 
system to combat malarial infection. Immunity to malarial infection 
involves cellular and humoral responses. A cellular immune response 
is mediated by T-lymphocytes, which plays an important role in the 
fight against the infection from intracellular sporozoites (skizogoni 
extraerythrocytic).
Kasumba turate (Carthamus tinctorius Linn.) flower from the 
Asteraceae family has empirically been used as traditional medication 
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by people in South Sulawesi to heal measles by brewing the plant in hot 
water before taking its juice, the consumption of which is believed to 
help increase body’s immunity system. A study on the ethanol extract 
of C. tinctorius Linn. discovered that the extract highly significantly 
increases both immunoglobulin G (IgG) and A (IgA) activities. Dried 
flowers of this plant can also be used as emmenagogue, laxant, or 
stimulant. In addition to consumption, its seed oil is used in mixture 
of cosmetic materials [6]. When tested on mice to determine its 
cellular immune response, the immunomodulatory effect of juice 
extracted from Kasumba turate flower (C. tinctorius Linn.) was 
remarkably significant. A test on non-specific immune response 
showed that a dosage of 1.95 and 3.90 mg/kg bodyweight could 
increase phagocytosis speed as was indicated by the phagocytosis 
index: 1.72 and 1.88 (K > 1.5), and this was considered as a strong 
immunostimulation. This increases very significantly when the flower 
is brewed with hot water [7]. Ethanol extract of C. tinctorius Linn. 
showed a potential antimalarial activity with an IC50 1.06 µg/mL. 
Therefore, the present study is designed to evaluated antimalarial 
activities of various fractions (chloroform, N-butanol, and ethyl 
acetate fraction) of ethanol C. tinctorius flowers extract.
However, many malaria-affected areas of Assam where people entirely 
rely on ethnomedicinal practices are not yet explored. In the present 
study, an ethnobotanical survey was conducted in highly malaria-
affected seven districts, namely, Goalpara, Baksa, Kamrup, Morigaon, 
Nagaon, Dibrugarh, and Dhemaji of Assam and all the gathered 
information were scientifically analyzed and validated.
METHODS
Plant material
Flowers of Kasumba turate (C. tinctorius Linn.) were collected from 
bone, a regency in South Sulawesi and have previously been determined 
by Purwodadi LIPI in Pasuruan.
Extraction
3 kg of C. tinctorius Linn. flowers was extracted with 10 L of ethanol. The 
ethanolic extract was concentrated to dryness on rotatory evaporator. 
178.7 g of crude extract was suspended in distilled water and partitioned 
with chloroform, butanol, and ethyl acetate successively, which were 
in turn concentrated to dryness in vacuo on rotary evaporator. The 
ethanolic extract of the fraction was tested for it’s in vitro antimalarial 
activities on P. falciparum 3D7 using the 24-well µL plate and the candle-
jar method. Breeding is done in a petri-dish and done aseptically. P. 
falciparum 3D7 culture obtained from frozen deposits in-thawing and 
bread from Pharmacy Laboratory of Airlangga University, Surabaya, 
Indonesia. Blood sample with a density of over 2000 was employed. 
Serial decreasing concentrations of the crude extract of chloroform, 
butanol, and ethyl acetate fraction were tested for antimalarial activity. 
The following concentrations were used; 100; 10; 1.0; 0.1; and 0.01 
(mg/mL). Negative controls used dimethyl sulfoxide (DMSO) diluted 
in the same manner as diluting materials above test, to obtain final 
DMSO concentration is not more than 0.5%. Mixture and suspension 
test parasites (= test preparation) are then inserted into the candle-
jar and incubated in a CO2 incubator at a temperature of 37°C for 48 
h. After incubation for 48 h made a thin blood smear on glass object. 
Smear dried at room temperature, fixed with methanol, then, once dry 
stained with Giemsa and counted under a microscope parasitemianya 
with 1000 times magnification. Calculations performed on 5000’s 
erythrocytes.
Data analysis
The data obtained from in vitro antimalarial activities assay above is 
in the form of a number of parasite-infected erythrocytes (counted 
on around 5000 erythrocytes) were subsequently converted into 
parasitemia levels (percent parasitemia) and the percent inhibition of 
the test substance on the growth of the parasite.
Percent parasitemia calculated by the formula:
infected erythrocytes
% Parasitemia
The number of erythrocytes
= ∑
The percentage inhibition of parasite growth is calculated using the 
formula:
Xp% Inhibition  100% 100%
Xk
 = − × 
 
Based on the data about the inhibition and concentration of the tested 
materials, IC50, or the concentration of test materials that inhibit 
parasite growth by 50%, was then calculated using the probity analysis.
RESULTS
The crude ethanolic extract of C. tinctorius flowers inhibited 
P. falciparum 3D7 with IC50 = 1.06 µg/mL. In vitro antimalarial assay 
of P. falciparum strain 3D7 was conducted on the chloroform, butanol, 
and ethyl acetate fraction. The detailed results for each of partition are 
as shown in Table 1.
DISCUSSION AND CONCLUSION
The present study confirms the antimalarial activity fraction chloroform, 
butanol, and ethyl acetate of Carthamus tinctorius Linn. flowers. 
Chloroform fraction is not exhibited an IC50, so this fraction did not have 
antimalarial activities. Butanol fraction exhibited an IC50 5007,43 µg/
mL, and ethyl acetate fraction can inhibit parasitemia >50% with the 
highest inhibition at 100 µg/mL of 94.48%. Ethyl acetate fraction is 
highly active as antimalarial with an IC50 of 1.25 µg/mL. According to 
Kohler (2002), an extract whose IC50 value is lower than 50 (µg/mL) 
and a fraction whose IC50 value is lower than 25 (µg/mL) is considered 
effective antimalarial. Data on Table 1 summarize that the IC50 values 
of ethyl acetate fraction are lower than Kohler’s criteria. It can, 
therefore, be stated that the ethyl acetate fraction can serve as effective 
antimalarial. However, since the IC50 value of ethanolic extract is lower 
than ethyl acetate fraction, it can be concluded that ethanol has a more 
potential antimalarial activity. Therefore, it is necessary to isolate of 
C. tinctorius Linn. flowers according to the bioassay-guided isolation 
Table 1: Mean percentage inhibition and IC50 each partition 
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principle to obtain active compounds that can be used as a marker in 
the standardization of antimalarial materials, so that C. tinctorius Linn. 
flowers can be developed into phytopharmaca products.
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